Anavex Life Sciences Net Tangible Assets

Anavex Life Sciences (AVXL) currently reports a net tangible assets of $110M as of June 2026. That compares with $91M in the prior-year period — up 23.6% year over year. Use the charts on this page to explore Anavex Life Sciences's net tangible assets history and peer comparisons.

Anavex Life Sciences's net tangible assets increased from $91M to $110M — a 23.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Anavex Life Sciences reported $110M in net tangible assets as of June 2026. That compares with $91M in the prior-year period — up 23.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anavex Life Sciences, and consider following AVXL for alerts when major investors trade the stock.

Anavex Life Sciences is classified in the Healthcare sector. On net tangible assets, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AVXL with unrelated industries.